ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/20 | 1,213 | 1,218 | 1,182 | 1,195 | -31 | -2.5% | 517,600 |
| 2023/01/19 | 1,172 | 1,236 | 1,164 | 1,226 | +42 | +3.5% | 842,100 |
| 2023/01/18 | 1,137 | 1,197 | 1,134 | 1,184 | +54 | +4.8% | 855,400 |
| 2023/01/17 | 1,180 | 1,211 | 1,130 | 1,130 | -49 | -4.2% | 991,400 |
| 2023/01/16 | 1,199 | 1,219 | 1,175 | 1,179 | -35 | -2.9% | 680,800 |
| 2023/01/13 | 1,232 | 1,252 | 1,205 | 1,214 | -30 | -2.4% | 583,300 |
| 2023/01/12 | 1,254 | 1,261 | 1,208 | 1,244 | -9 | -0.7% | 669,900 |
| 2023/01/11 | 1,280 | 1,317 | 1,045 | 1,253 | -15 | -1.2% | 2,959,700 |
| 2023/01/10 | 1,307 | 1,319 | 1,265 | 1,268 | -29 | -2.2% | 427,000 |
| 2023/01/06 | 1,246 | 1,302 | 1,242 | 1,297 | +29 | +2.3% | 439,400 |
| 2023/01/05 | 1,288 | 1,303 | 1,266 | 1,268 | -10 | -0.8% | 514,700 |
| 2023/01/04 | 1,345 | 1,350 | 1,268 | 1,278 | -115 | -8.3% | 1,153,400 |
| 2022/12/30 | 1,351 | 1,418 | 1,324 | 1,393 | +49 | +3.6% | 1,208,600 |
| 2022/12/29 | 1,221 | 1,353 | 1,215 | 1,344 | +110 | +8.9% | 1,584,000 |
| 2022/12/28 | 1,331 | 1,331 | 1,213 | 1,234 | +23 | +1.9% | 2,261,600 |
| 2022/12/27 | 1,199 | 1,232 | 1,199 | 1,211 | +23 | +1.9% | 653,700 |
| 2022/12/26 | 1,202 | 1,213 | 1,188 | 1,188 | -13 | -1.1% | 516,800 |
| 2022/12/23 | 1,198 | 1,215 | 1,193 | 1,201 | -10 | -0.8% | 380,900 |
| 2022/12/22 | 1,231 | 1,238 | 1,198 | 1,211 | ±0 | ±0% | 539,800 |
| 2022/12/21 | 1,241 | 1,249 | 1,210 | 1,211 | -29 | -2.3% | 646,700 |
| 2022/12/20 | 1,303 | 1,309 | 1,222 | 1,240 | -75 | -5.7% | 1,119,900 |
| 2022/12/19 | 1,340 | 1,345 | 1,312 | 1,315 | -36 | -2.7% | 463,100 |
| 2022/12/16 | 1,352 | 1,364 | 1,344 | 1,351 | -27 | -2% | 382,400 |
| 2022/12/15 | 1,382 | 1,396 | 1,378 | 1,378 | -6 | -0.4% | 197,300 |
| 2022/12/14 | 1,402 | 1,405 | 1,376 | 1,384 | +1 | +0.1% | 285,500 |
| 2022/12/13 | 1,405 | 1,419 | 1,380 | 1,383 | -8 | -0.6% | 243,100 |
| 2022/12/12 | 1,380 | 1,408 | 1,370 | 1,391 | -9 | -0.6% | 340,000 |
| 2022/12/09 | 1,392 | 1,404 | 1,380 | 1,400 | +16 | +1.2% | 303,200 |
| 2022/12/08 | 1,407 | 1,416 | 1,368 | 1,384 | -36 | -2.5% | 547,800 |
| 2022/12/07 | 1,404 | 1,425 | 1,391 | 1,420 | +2 | +0.1% | 295,300 |
| 2022/12/06 | 1,430 | 1,462 | 1,417 | 1,418 | -20 | -1.4% | 353,300 |
| 2022/12/05 | 1,442 | 1,447 | 1,401 | 1,438 | -9 | -0.6% | 302,100 |
| 2022/12/02 | 1,455 | 1,474 | 1,438 | 1,447 | +10 | +0.7% | 512,900 |
| 2022/12/01 | 1,432 | 1,446 | 1,418 | 1,437 | +25 | +1.8% | 353,700 |
| 2022/11/30 | 1,427 | 1,444 | 1,406 | 1,412 | -2 | -0.1% | 475,800 |
| 2022/11/29 | 1,395 | 1,424 | 1,378 | 1,414 | +9 | +0.6% | 386,800 |
| 2022/11/28 | 1,407 | 1,430 | 1,391 | 1,405 | -15 | -1.1% | 538,900 |
| 2022/11/25 | 1,451 | 1,457 | 1,414 | 1,420 | -45 | -3.1% | 515,100 |
| 2022/11/24 | 1,495 | 1,512 | 1,456 | 1,465 | -35 | -2.3% | 527,200 |
| 2022/11/22 | 1,478 | 1,503 | 1,462 | 1,500 | ±0 | ±0% | 440,100 |
| 2022/11/21 | 1,507 | 1,527 | 1,471 | 1,500 | +16 | +1.1% | 688,200 |
| 2022/11/18 | 1,445 | 1,503 | 1,433 | 1,484 | +39 | +2.7% | 706,800 |
| 2022/11/17 | 1,511 | 1,528 | 1,445 | 1,445 | -102 | -6.6% | 1,104,000 |
| 2022/11/16 | 1,610 | 1,650 | 1,543 | 1,547 | -25 | -1.6% | 1,176,600 |
| 2022/11/15 | 1,575 | 1,669 | 1,522 | 1,572 | +92 | +6.2% | 2,050,300 |
| 2022/11/14 | 1,452 | 1,493 | 1,444 | 1,480 | +29 | +2% | 497,900 |
| 2022/11/11 | 1,456 | 1,472 | 1,437 | 1,451 | +33 | +2.3% | 520,400 |
| 2022/11/10 | 1,388 | 1,427 | 1,377 | 1,418 | +19 | +1.4% | 270,800 |
| 2022/11/09 | 1,434 | 1,448 | 1,398 | 1,399 | -34 | -2.4% | 277,400 |
| 2022/11/08 | 1,420 | 1,453 | 1,418 | 1,433 | +25 | +1.8% | 321,200 |
551～
600
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 222,700円 | +21.7% | +999.9% | 0.00% | 9.27倍 | 3.07倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 450,000円 | +7.1% | -35.0% | 2.67% | 37.21倍 | 1.04倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 230,400円 | +14.2% | +41.0% | 2.00% | 11.28倍 | 1.15倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 306,500円 | +3.0% | +27.5% | 2.61% | 19.40倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
